(Q54288737)

English

Targeted therapies: Hippo effector YAP1 inhibition—towards a new therapeutic option to overcome drug resistance.

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25707626

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25707626

title

Targeted therapies: Hippo effector YAP1 inhibition—towards a new therapeutic option to overcome drug resistance. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25707626

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25707626

author name string

Alessia Errico

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25707626

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25707626

language of work or name

English

0 references

publication date

24 February 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25707626

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25707626

published in

Nature Reviews Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25707626

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25707626

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25707626

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25707626

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25707626

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25707626

page(s)

190

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25707626

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25707626

cites work

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/25707626

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRCLINONC.2015.31

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25707626

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25707626

PubMed publication ID

25707626

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25707626

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25707626

(Q54288737)

Targeted therapies: Hippo effector YAP1 inhibition—towards a new therapeutic option to overcome drug resistance.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)